Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950170-25-059288
Filing Date
2025-04-28
Accepted
2025-04-28 16:05:08
Documents
17
Period of Report
2025-06-09

Document Format Files

Seq Description Document Type Size
1 DEF 14A sprb-20250428.htm   iXBRL DEF 14A 775889
2 GRAPHIC img34232395_0.jpg GRAPHIC 2036
3 GRAPHIC img34232395_1.jpg GRAPHIC 3052
4 GRAPHIC img34232395_2.jpg GRAPHIC 3052
5 GRAPHIC img34232395_3.jpg GRAPHIC 148765
6 GRAPHIC img34232395_4.jpg GRAPHIC 124872
  Complete submission text file 0000950170-25-059288.txt   1749084

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT sprb-20250428.xsd EX-101.SCH 7970
19 EXTRACTED XBRL INSTANCE DOCUMENT sprb-20250428_htm.xml XML 6116
Mailing Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BOULEVARD, SUITE 740 SOUTH SAN FRANCISCO CA 94080 (415) 655-4168
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

EIN.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39594 | Film No.: 25880223
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)